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Background: Ketogenic diets (KDs) have gained some popularity not only as 
effective weight-loss diets and treatment options for several diseases, but also 
among healthy and physically active individuals for various reasons. However, 
data on the effects of ketosis in the latter group of individuals are scarce. We 
therefore collected pilot data on the physiological response to a self-prescribed 
ketogenic diet lasting 5-7 weeks in a small cohort of healthy and physically active 
individuals. 
Methods: Twelve subjects (7 males, 5 females, age 24-60 years) who followed 
moderate to intensive exercise routines underwent blood testing, bioelectrical 
impedance analysis (BIA) and spiroergometry during an incremental treadmill 
test. On the next day, they went on a self-prescribed KD for a median of 38 days 
(range 35-50 days), after which the same tests were performed again. Ketosis 
was self-monitored by urinary ketone strips. Subjective feeling during the diet 
was assessed by a questionnaire after the intervention. Due to the small and 
heterogenous sample, the results are interpreted in the context of the already 
existing literature. 
Results: The KDs were tolerated well by the majority of individuals. Impaired 
recovery from exercise remained the most frequently reported side effect until 
the end of the study. Most blood parameters remained stable during the 
intervention. However, there were significant elevations of total and LDL 
cholesterol concentrations (p<0.01) and a trend towards increased HDL-
cholesterol (p=0.05). The drastic reduction of carbohydrates had no statistically 
significant influence on running performance judged by the time to exhaustion, 
VO2max and respiratory compensation points. BIA measurements showed 
significant increases in phase angle (p=0.01) indicating improvements of body 
composition with an estimated decrease of 3.4 kg of fat mass (p=0.002) and gain 
of 1.3 kg of fat free mass. We discuss the validity of these estimates taking into 
account a possibly altered hydration status due to the KD.  
Conclusions: Active healthy individuals will probably experience no major 
problems during a short term KD lasting several weeks. The drastically reduced 
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performance. In addition, improvements in body composition can be expected. 
While most biochemical parameters are not influenced by the diet, there seems 
to be an impact on the blood lipid profile that could be considered problematic 
with respect to cardiovascular disease risk. However, the predictive role of 
cholesterol levels alone in individuals undergoing regular physical activity 
remains to be elucidated. 
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BACKGROUND 
Ketogenic diets (KDs) are characterized by a 
very low carbohydrate (CHO, <30-50 g/day) 
and compensatory high fat content that lead 
to low insulin and subsequently increased 
ketone body levels in serum, also termed 
ketosis. Ketosis seems to have beneficial 
effects in certain pathological conditions, 
most notably epilepsy where it is the 
treatment of choice for patients with drug-
resistant intractable seizures [1, 2], but also 
metabolic syndrome [3–5] , cancer [6] and 
possibly Alzheimer's and other neurode-
generative disorders [7]. In addition, KDs 
have gained much popularity as weight-loss 
diets, where they have been shown to be at 
least as effective or even superior to 
traditional low-fat diets in obese individuals 
[8–12] with the additional benefit of 
favourably influencing risk factors for 
cardiovascular disease. 
But can a KD be recommended also for 
healthy individuals? This question is justified 
because we cannot a priori expect the same 
effects from a particular diet to happen in two 
groups of individuals that have different 
metabolism, lifestyle habits and health status. 
Surprisingly, the literature on the effects of 
KDs in healthy and physically active indivi-
duals is scarce, although in our experience 
such diets have some popularity among 
metabolically normal people and even 
athletes. First, formerly obese individuals 
who succeeded in losing weight on a KD 
might like to continue with this lifestyle 
change. Second, physically active people often 
aim at optimizing their lean- to fat-mass ratio 
or losing a few kilograms of weight in prepa-
ration for a competitive or social event. Third, 
many athletes are interested in improving 
their ability to mobilize their fat stores for 
fuel during exercise, especially in long 
endurance races. Indeed, studies suggest that 
KDs dramatically shift the substrate utili-
zation from glucose to fat (and ketone bodies) 
at submaximal training intensities [13–18]. In 
their seminal study on trained cyclists, 
Phinney et al. further proved that at these 
intensities exercise performance can be con-
served when allowing for a few weeks of 
adaption to a KD [15]. Similarly, Brinkworth 
et al. showed that an 8-week KD had no 
detrimental effects on exercise performance 
in a treadmill test to exhaustion in untrained 
obese subjects [18]. This contrasts to similar, 
but shorter-term studies that have reported 
reduced capacity for endurance exercise [19, 
20]. Recently, Paoli et al. [21] demonstrated 
that a KD could be an option for athletes who 
want to lose fat mass without compromising 
muscle mass and strength. In this study, nine 
elite artistic gymnasts lost an average of 
1.9 kg fat while maintaining their perfor-
mance in several anaerobic strength tests 
over a period of 30 days. It should be noted, 
however, that these authors defined their diet 
as ketogenic despite a mean protein energy 
content of 40.7 % (i.e. 201 grams daily, surely 
above the protein needs of the athletes) and 
without providing information on ketone 
body measurements. High protein levels 
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diminish ketone production by favouring 
gluconeogenesis from abundant amino acids 
as already described by Hirschfeld in 1885 
[22]. 
Only a few other studies have examined 
the metabolic and physiological responses to 
a KD lasting at least several weeks in healthy 
and physically active individuals. The first 
one was the study on the arctic explorer 
Vilhjalmur Stefansson and his comrade 
Karsten Andersen who consumed a diet of 
solely meat and fat for 12 months [23–25]. 
Besides an elevation in total cholesterol 
levels, no adverse effects on biochemical 
parameters, blood pressure or kidney 
function were noted and the two men 
“carried on their usual activities without any 
increase of fatigue while taking meat” [24]. In 
1967 Krehl et al. [26] studied four normal-
weight men who underwent supervised 
physical activity daily and ingested a KD of 
varying protein and fat content for a total of 
five months, whereby two of the men 
received an additional 50 g of CHO daily. The 
most significant changes were an increase in 
total cholesterol levels that was less 
pronounced in the men receiving the extra 
CHOs, and in blood urea nitrogen that 
increased in accordance with the protein 
content of the diet. 14 years later, Elliot et al. 
[27] confirmed these findings in a young 
female and male who ingested a KD for 24 
days and showed that the increase in 
cholesterol levels was mainly due to an 
increase of LDL concentration. This led the 
authors to express deep concerns about the 
safety of a KD, because at that time LDL 
concentrations emerged as strong positive 
predictors of cardiovascular disease (CVD) 
risk. However, the results of an experiment 
published by Matthew Sharman, Jeff Volek 
and colleagues indicate that despite a rise in 
LDL concentrations, the overall cardio-
vascular risk profile could change in a 
favourable way during a KD, e. g. by increased 
HDL and lowered triglyceride concentrations 
[28, 29]. This fits well with observations of an 
improvement of serum lipid patterns in obese 
adults after a one year KD despite increased 
LDL concentrations [12]. That LDL con-
centrations levels stay elevated during long-
term consumption of a KD is further 
suggested from a Polish cross-sectional study 
of 31 healthy individuals who ate according 
to the so-called “optimal diet” for at least one 
year [30]. Although not strictly ketogenic, the 
“optimal diet” consisted of about 75 % energy 
from fat. Most of the LDL and total cholesterol 
concentrations exceeded the reference 
ranges, yet the “optimal” dieters showed very 
low risk for CVD as judged by other predictive 
parameters. 
The paucity of data regarding physiolo-
gical changes that occur in healthy individuals 
on a KD implies a high uncertainty in 
predicting these changes; in addition, large 
individual differences seem to exist in the 
response to a KD. From our experience coun-
selling cancer patients (UK) or athletes (JP), 
most individuals are highly interested in how 
the KD affects their ability to exercise. We 
therefore set out to collect new data on the 
effects of a KD in healthy and physically active 
individuals to add to and interpret in the 
context of the existing literature. We decided 
to study the effects of a KD as it would be 
adopted in a real-life situation by self-
motivated, physically active and healthy 
individuals, focussing on changes of physical 
performance measures and biochemical 
parameters. In this paper we report on 
results from twelve subjects who were willing 




MATERIALS AND METHODS 
Study design 
This study was designed as an interventional 
case study without control group. The trial 
was conducted between 14 February 2012 
and 10 August 2012. All testing procedures 
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were performed at PREDIA prevention and 
diagnostic center (PREDIA GmbH, Würzburg, 
Germany), which also provided the casualty 
insurance for our study subjects. All inter-
ventions were done in accordance with the 
International Conference on Harmonization 
guidelines and the Declaration of Helsinki and 
Good Clinical Practice guidelines [31]. 
 
Study participants 
We searched for physically active adult 
study participants among private contacts 
and members of a local triathlon and weight 
lifting club. Exclusion criteria were defined as 
a previous diagnosis of the metabolic syn-
drome or usage of a KD during the six months 
prior to recruitment. After explaining the 
goals and course of the experiment as well as 
the possible side-effects associated with a KD 
and risks of the testing procedures, a total of 
ten individuals (six men and four women) 
volunteered to participate; in addition, two of 
the authors (RK and UK) took part in the 
study. All participants signed a written in-
formed consent form prior to the first tests. 
Subjects had a high socioeconomic status and 
were physically active, non-smoking and – 
since we were not able to offer financial 
compensation – highly motivated. None of the 
subjects took any medication except for 
subject 11 who used a thyroxin substitute at 
75µg/day. Subjects 1, 2, 4 and 11 had already 
tested ketogenic diets temporarily before, but 
in no case during the six months preceding 
the study initiation. The remaining eight 
persons had no experience with low CHO 
diets or ketogenic diets before starting the 
trial. 
Details of our study participants concer-
ning the type and duration of their training 
are provided in Table 1. 
 
Testing procedure 
On day zero (subsequently denoted PRE), 
participants reported to the lab after fasting 
for at least 6 hours. They were advised to 
restrain from strenuous exercise the day 
before as if preparing for a hard training 
session. Venous blood samples were collected 
into tubes containing either EDTA (blood 
count analysis) or sodium fluoride (glu-
cose/lactate analysis) or no additive (serum 
generation for all other analyses). The serum 
tubes were stored at room temperature for 
15 minutes to allow clotting of the blood 
samples and then centrifuged at 1500 g at 
4 °C. The serum was then transferred to a 
new tube, and all tubes were sent 
immediately to the central laboratory of the 
University Hospital of Würzburg for routine 
laboratory analysis. Shortly, complete blood 
count without differential was performed on 
a XE 2100 automated hematology system 
(Sysmex Europe GmbH, Norderstedt, 
Germany). The chemistry/biochemistry panel 
was analyzed with the Cobas 8000 modular 
analyzer series (Roche Diagnostics; 
Mannheim, Germany). 
Next, we performed bioelectrical impe-
dance analysis (BIA) measurements following 
a standardized procedure according to the 
ESPEN guidelines described in Table 1 of Kyle 
et al. [32]. Electrodes were placed on hand 
and wrist and foot and ankle, and resistance R 
and reactance Xc to a 50 kHz current were 
measured by the BIA device (BIA 101; Akern 
Srl, Florence, Italy). The phase angle α, given 
as α = arctan(Xc/R), was also recorded and 
uncertainties for α derived from the 
uncertainties of R and Xc given by the 
manufacturer as ±1 Ohm and ±2 Ohm, 
respectively. Each subject’s height, weight 
and age were used together with R and Xc to 
estimate extracellular water (ECW), intra-
cellular water (ICW), total body water (TBW 
= ECW+ICW), body cell mass (BCM), extra-
cellular mass (ECM), fat free mass (FFM = 
BCM+ECM) and fat mass (FM = body weight-
FFM) based on standard equations applicable 
to healthy adult individuals. 
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Tab. 1: Characteristics of our study subjects at PRE. 
 














1 male 32 74.9 182 22.6 Triathlon 10 11 
2 male 29 78.5 183 23.4 Triathlon 6 6 
3 male 29 77.5 180 23.9 Soccer 4 4 
4 male 32 80.5 176 26.0 Tennis 2 3 
5 male 24 87.4 186 25.3 Cycling 5 6 
6 male 60 70.1 176 22.6 Running 2 2 
7 male 36 93.5 172 31.6 Weight lifting 4 6 
8 female 32 61 165 22.4 Triathlon 6 10 
9 female 25 68.7 164 25.5 Triathlon 6 7 
10 female 24 68.3 178 21.6 Running 2 1 
11 female 46 72.4 171 24.8 Fitness 
training 
3 4.5 





To take into account the intra-individual 
prediction errors in FFM given as 3.5-6 % by 
Kyle et al. [33], we generated for each subject 
100000 Monte Carlo simulations of FFM and 
FM, whereby for calculation of the latter we 
neglected any uncertainties in weight 
measurements. Briefly, a new FFM measure-
ment was simulated by drawing a random 
number with mean located at our measure-
ment value and standard deviation equal to 
the assumed prediction error. Simulated p-
values were obtained as the percentage of 
simulated datasets in which FM increased and 
FFM decreased, respectively. 
Fifteen to thirty minutes after the BIA 
measurement, a graded running test to 
exhaustion was performed on a treadmill 
(Jaeger LE 580 C) to determine maximal 
oxygen consumption (VO2max) and substrate 
turnover at a given workload. During the test, 
air temperature was kept at 20-22 °C. Heart 
rate (HR) was monitored (Sport Tester; Polar 
Electro, Kempele, Finland) and oxygen con-
sumption rate (VO2), carbon dioxide pro-
duction rate (VCO2) and ventilation (VE) was 
recorded on a breath-by-breath basis (Jaeger 
Oxycon Pro, Carefusion Germany 234 GmbH, 
Höchberg, Germany). The gas analyser was 
calibrated with known gas mixtures 
(14.99 Vol% O2 and 5.80 Vol% CO2). Subjects 
started to run at 7.5 km/h. Every 3 min, 
velocity increased by 1.5 km/h until 
voluntary exhaustion was reached. VO2max 
was determined at the point where (i) the 
oxygen consumption rate increased less than 
1 ml kg-1 min-1 despite an increase in 
intensity, or (ii) the respiratory gas exchange 
quotient (RQ) reached 1.1. Alternatively, 
VO2peak was estimated as the average oxygen 
consumption rate during the last 30 s if 
voluntary exhaustion was reached before 
conditions (i) and (ii). The respiratory 
compensation point (RCP) was determined 
from the minimum in the VE/VCO2 curve with 
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relative heart rate as the reference [34]. After 
every three minutes, the treadmill slowed 
down for 30 s so that subjects could stand 
beside it for taking a 10 μl capillary sample 
from the ear lobe. In this way, samples were 
taken at rest, every three minutes during 
exercise, at time of exhaustion and three 
minutes after exercise and blood lactate and 
glucose concentrations were determined 
using an Super GL Ambulance Lactate 
Analyser (Dr. Müller Gerätebau GmbH, 
Freital, Germany) which according to the 
manufacturer has a 24 samples variation 
coefficient <1.5 % for glucose and <2.5 % for 
lactate. 
The same testing routine was used for the 
final examination, which took place 35 to 50 
days (median 38 days) after starting the KD 
(subsequently denoted as POST). 
 
Study intervention 
The duration of the study was initially 
chosen to last approximately from the 
beginning until the end of the paschal fasting 
period (~ 40 days), in part to enhance moti-
vation for some individuals. 
Subjects were provided with handouts 
similar to those used in the study of Cervenka 
et al. [35]. The handouts summarized the 
main aspects of a ketogenic diet and included 
a list of suitable foods with very low CHO 
content as well as ideas for suitable meals. 
Furthermore, subjects were provided with 
cooking recipes and an information brochure 
which had been created for a KD study with 
cancer patients [36]. We advised the partici-
pants to eat ad libitum, but limit their CHO 
intake to a maximum of 20 g/day with no 
more than 5-7 g digestible CHO per meal and 
to derive at least 75 % of energy from fat. 
Apart from that, subjects were free to design 
their KD according to their preferences 
without any further nutritional counselling. 
However, we offered to answer any questions 
that might arise in context with the KD via 
email, phone or personal contact. Recently, 
Cervenka et al. have shown that administe-
ring a KD over three months solely via email 
is feasible and effective in adults with 
relatively high socioeconomic status, which 
was also the case for all our participants [35]. 
Each subject also received 50 reagent 
strips for self-testing of urinary acetoacetate 
(Ketostix; Bayer, Basel, Switzerland). The 
handouts included a calendar to document 
daily measurements of urinary ketones and 
weight; the former ought to be taken 
preferably in the afternoon and not after 
exercise, the latter in the morning before 
breakfast. In addition, we obtained a random 
sample of three-day food diaries from five 
participants which were analysed using the 
software DGE-PC professional version 
2.8.026. 
Importantly, in order to not bias the 
results of the second treadmill test, we 
advised all participants to maintain their 
usual training frequency during the study 
intervention without increasing or decreasing 
the training load. 
After the study, each subject received a 
short non-validated questionnaire designed 
by the authors via email addressing several 
aspects of their subjective feeling during the 
KD (see Additional file 1). 
 
Statistical analysis 
Due to our heterogeneous sample popula-
tion and small sample size, we use median, 
minimum and maximum values to charac-
terize parameter distributions. The Wilcoxon 
signed rank sum test for paired samples is 
used to test the null hypotheses that no 
changes in a parameter of interest occurred 
from pre- to post-diet. Due to the explorative 
nature of this trial and our small sample size, 
we report two-sided p-values but refrain 
from using p-value corrections [37]. Thus, p-
values <0.05 should be considered a trend 
and p<0.01 significant in the sense that 
further studies are needed to confirm our 
findings. As an alternative to post-hoc power 
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analysis, we provide 95 % confidence inter-
vals (CIs) for all parameter changes. Descrip-
tive statistics are used to summarize the 
results of our non-validated questionnaire. All 
statistical tests have been conducted using R 




All subjects completed the study with no 
major side effects. Median time on the diet 
was 38 days (range 35-50 days). Urinary 
ketone tests were recorded on 95 % of the 
days (92-100 %). Median time until the first 
appearance of acetoacetate in the urine was 4 
days (1-5 days). Thereafter, a median of 95 % 
(59-100 %) of urinary ketone tests were 
positive, ranging between 0.5 and 16 mmol/l 
(median 1.5 mmol/l). 
According to software-based analysis of 
three-day food records from five subjects the 
mean intake of CHOs was 16.5±1.1 g/day and 
therefore as low as prescribed (<20 g). 
Energy intake for the two males and three 
females was 3050±1360 kcal/day and 
2030±330 kcal/day, respectively. The mean 
relative energy intake of CHOs, fats and 
protein was 3.0±0.4 %, 68±5 % and 29±5 %, 
respectively. Fat intake was composed of 
69±33 g/day saturated, 93±55 g/day mono-
unsaturated, 3.1±0.6 g/day omega 3 and 
16.3±8 g/day omega 6 fatty acids as well as 
1.2±0.6 g/day cholesterol, contributing 
26±6 %, 34±7 %, 1.2±0.3 %, 6.1±1.1 % and 
0.4±0.2 % to total energy intake, respectively. 
 
Individual tolerance to a ketogenic diet 
As already stated, study participants were 
highly motivated in the beginning. Some 
minor side effects like dizziness, headaches or 
general weakness disappeared within the 
initial 1-2 weeks after implementing the diet. 
However, subject 3 reported to be in a bad 
mood for most of the time and complained 
about limited food choices and bad 
practicability of the diet; nevertheless, he 
continued with the diet for a total of 37 days, 
of which he recorded elevated ketone bodies 
on 26 days. 
Ten of our twelve subjects returned the 
questionnaires we sent out after the study 
(see Additional file 1). Practicability of the 
diet was judged as “very easy” or “easy” by 
four and five of the subjects, respectively, 
while subject 3 judged it as “difficult”. Effects 
on satiety were highly heterogeneous, with 
four subjects reporting no changes in hunger, 
four subjects reporting less hunger and two 
subjects more hunger than before. The most 
frequently missed food items were fruits 
(eight subjects) followed by unlimited 
amounts of vegetables (four subjects). Only 
two subjects reported a craving for other 
foods like baked goods. Most subjects were 
able to continue with their usual training, 
albeit with minor problems including in-
creased perceived exertion and subjectively 
increased needed time of recovery. Three 
subjects had to decrease their training load 
due to impaired recovery and the inability to 
complete high intensity workouts. In parti-
cular, subject 1 lost a total of 12 training days 
due to an acute sinusitis starting on day 7 of 
the diet with subsequent relapse on day 29. 
For this reason, we decided to extend his diet 
period to 50 days. All participants consisten-
tly noted a subjective improvement in perfor-
mance after 2-3 weeks and all but one 
reported feeling “very good” or “good” when 
not exercising. Positive reported effects that 
subjects related to the diet included less 
tiredness or improved power of concen-
tration, respectively (four subjects) and 
feeling more balanced (three subjects). 
Impaired recovery after physical exercise at 
high intensities was reported to remain the 
strongest side effect until the end of the diet. 
 
Anthropometric parameters 
Most subjects experienced a decrease in 
body weight over the course of the study. The 
median self-monitored relative weight change 
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until day 35 for the whole group was -3.1 % 
(p=0.02). The difference between the first and 
last of the self-performed weight measure-
ments was highly correlated to the difference 
between our laboratory measurements at 
PRE and POST (r=0.93, p<0.0001), proving 
the validity of the self-monitoring. 
Our BIA measurements indicate that the 
KD induced pronounced changes in body 
composition (Table 2 and Figure 1). The 
phase angle α increased significantly from a 
median of 6.6° (4.8°-7.9°) to 6.9° (6.1°-8.6°) 
(p=0.01), leading to significant changes in 
other indirectly derived quantities: increases 
of intracellular water (ICW) from 24.8 l to 
27.3 l (p=0.003) and body cell mass (BCM to 
which ICW contributes) from 32.3 kg to 
35.8 kg (p = 0.003) as well as a decrease of fat 
mass (FM) from 16.4 kg to 13.0 kg (p = 
0.002). Fat free mass (FFM) increased from 
57.5 kg to 58.6 kg (p = 0.08) and extra-cellu-
lar water (ECW) decreased from 18.6 kg to 
17.4 kg (p = 0.08) at POST. As an alternative 
representation, we have plotted these 
changes scaled to body height in Figure 1.  
 
 
Figure 1: Box and whisker plot of changes in phase 
angle and body composition estimates from our 
bioimpedance measurements. The latter have been 
scaled to the individual’s body height. Alpha: Phase 
angle; FM: Fat mass; FFM: Fat free mass; BCM: Body 




Blood cell counts and serum minerals 
No significant changes were observed in 
the count of blood platelets as well as 
leucocytes and their different subtypes 
(Table 3). There was a trend, however, for an 
increase in the percentage of eosinophil 
granulocytes. Hematocrit increased slightly, 
probably due to hemoconcentration because 
of water loss induced by the KD; the ratio 
between hematocrit and red blood cell count 
(MCV) remained fairly stable. 
Despite not explicitly advising our subjects 
to supplement with extra minerals, the 
concentration of sodium, potassium and 
calcium remained stable and well within the 
reference ranges. Subjects 9, 10 and 11 
initially had iron concentrations outside the 
reference range (31, 192 and 179 μg/dl, 
respectively) which normalized to 53, 67 and 
120 μg/dl at POST. Ferritin concentrations for 
the whole group remained statistically un-
changed, but in one of our female participants 
(subject 10) with a low value at PRE 
(26 ng/ml) ferritin had decreased further to 
13 ng/ml at POST. 
 
Liver and kidney parameters 
The liver and kidney parameters are 
summarized in Table 4. We noted a trend 
towards an increase in the liver enzyme GPT. 
However, none of the subjects exceeded the 
reference range for this parameter. No 
changes between PRE and POST could be 
noted in concentrations of CRP, alkaline 
phosphatase and gamma-glutamyltransfe-
rase. Subject 9, however, initially showed an 
elevated CRP concentration of 3.46 mg/dl, 
possibly due to an acute infection. At POST 
this value had normalized to 0.23 mg/dl. 
Renal function was assessed by measuring 
the concentrations of creatinine, uric acid and 
blood urea nitrogen (BUN). Increases 
occurred in all three parameters, the increase 
in creatinine levels showing a clear trend 
(p=0.016, 95 % CI for change from PRE to 
POST [0.03,0.16]).  
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Body cell mass 
[kg] 
 PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST 
1 75.0 72.0 7.9 8.6 17.9 18.2 28.9 32.0 64.0 68.7 11.0 3.3 39.8 44.2 
2 78.5 78.0 7.1 7.6 19.5 19.4 27.9 29.7 64.7 67.1 13.8 10.9 38.1 40.7 
3 77.5 73.7 6.8 8.4 18.9 16.5 25.8 28.4 61.0 61.4 16.5 12.3 35.1 39.2 
4 80.5 75.0 6.4 7.6 21.5 18.3 27.4 28.3 66.8 63.6 13.7 11.4 37.2 38.8 
5 87.4 86.8 6.8 7.2 21.0 20.5 28.6 30.0 67.8 69.0 19.6 17.8 38.9 41.0 
6 70.2 67.8 6.1 7.1 19.4 18.3 23.7 26.3 53.9 55.7 16.2 12.1 29.4 32.8 
7 93.5 92.1 7.0 6.6 21.1 21.8 29.7 29.0 69.5 69.5 24.0 22.6 40.6 39.4 
8 61.0 59.0 5.9 6.3 15.3 14.7 17.9 18.5 45.3 45.3 15.7 13.7 24.1 25.0 
9 67.7 70.1 6.1 6.4 16.8 16.2 20.3 20.8 50.7 50.4 18.0 19.7 27.5 27.8 
10 68.4 66.3 4.8 6.1 18.3 16.4 16.8 20.0 48.0 49.8 20.3 16.5 22.5 27.1 
11 72.4 70.8 5.8 6.3 16.9 16.3 19.3 20.4 49.5 50.2 22.9 20.6 26.1 27.7 
12 48.5 48.8 6.7 6.5 12.2 12.8 16.4 16.7 39.1 40.3 9.4 8.5 22.3 22.6 
Median 73.7 71.4 6.6 6.9 18.6 17.4 24.8 27.3 57.5 58.6 16.4 13.0 32.3 35.8 
95% CI [-3.0,-0.5] [0.2,1.0] [-1.5,0.05] [0.6,2.3] [-0.7,2.5] [-4.1,-1.4] [0.9,3.3] 
p-value 0.02 0.01 0.08 0.003 0.08 0.002 0.003 
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p-value  95 % CI 
Leucocytes (103/mm3) 5.6 (4.3 – 7.5) 5.1 (4.7 – 6.4) 4.0-10.0 0.61 [-0.8,0.4] 
Erythrocytes (106/μl) 4.7 (4.4 - 5.2) 4.8 (4.4 – 5.4) 4.4-5.9 0.19 [-0.1,0.3] 
Lymphocytes (%) 28 (17 - 48) 31 (20 - 45) 20-40 0.78 [-5,8] 
Monocytes (%) 6 (4 - 9) 6 (4 - 10) 0-10 0.52 [-1.5,1] 






1 (0 - 1) 
2 (1 - 5) 
59 (43 - 74) 
 
1 (0 - 1) 
3 (1 - 7) 













Hemoglobin content (g/dl) 14.1 (12.9 – 16.0) 14.3 (12.5 – 15.8) 13.3-17.7 0.29 [-0.3,0.6] 
Hematocrit (%) 42.8 (38.6 – 46.8) 43.3 (39.0 – 47.7) 40.0-52.0 0.06 [-0.2,2.6] 
MCV (fl) 89 (86 - 95) 90 (87 - 94) 81-100 0.33 [-1,2] 
MCH (pg) 30.0 (28.3 – 31.0) 29.8 (28.0 – 30.3) 27.0-34.0 0.27 [-0.85,0.55] 
MCHC (g/dl) 33.6 (32.4 – 34.7) 33.2 (31.9 – 34.1) 31.5-36.3 0.08 [-1.1,0.15] 
HbA1c (%) 5.6 (5.3 – 5.7) 5.4 (5.0 – 5.8) <6.1 0.11 [-0.35,0.05] 
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p-value  95 % CI 
Sodium (mmol/l) 140 (137 - 142) 140 (137 - 144) 135-148 0.76 [-3,2] 
Potassium (mmol/l) 3.97 (3.73 – 4.46) 4.07 (3.71 – 4.39) 3.70-5.00 0.73 [-0.13,0.15] 
Calcium (mval/l) 4.73 (4.36 – 5.14) 4.70 (4.45 – 5.09) 4.20-5.20 0.52 [-0.18,0.15] 
Iron (μg/dl) 90 (31 - 192) 72 (42 - 120) 59-158 0.10 [-60,7] 
Ferritin (ng/ml) 54 (25 - 411) 88 (14 - 381) 30-350 0.57 [-9,41] 
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p-value  95 % CI 
CRP (mg/dl) 0.07 (0.04 – 3.46) 0.10 (0.04 – 0.82) <0.50 0.92 [-1.6,0.3] 
GOT (U/l) 25 (14 - 40) 27 (15 - 53) <51 0.31 [-2,7] 
GPT (U/l) 22 (10 - 115) 29 (11 - 39) <51 0.05 [0,10] 
Gamma GT (U/l) 13 (8 - 33) 13 (8 - 20) <66 0.23 [-10,1] 
Alkaline Phosphatase (U/l) 56 (39 - 70) 54 (37 - 67) 40-142 0.43 [-7,4] 
Total protein (g/dl) 7.14 (6.86 – 7.44) 7.08 (6.59 – 7.34) 6.50-8.00 0.18 [-0.38,0.17] 
Creatinine (mg/dl) 0.92 (0.69 – 1.23) 1.02 (0.74 – 1.36) <1.20 0.02 [0.03,0.16] 
Blood Urea Nitrogen (mg/dl) 33 (22 - 47) 39 (19 - 48) <50 0.16 [-2,11] 
Uric acid (mg/dl) 4.5 (2.8 – 6.3) 4.7 (3.1 – 6.9) <7.0 0.15 [-0.3,1.2] 
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p-value  95 % CI 
Glucose (mg/dl) 94 (86 - 110) 88 (74 - 108) 60-110 0.21 [-14,3] 
Triacylglycerides (mg/dl) 64 (26 - 91) 76 (35 - 110) <170 0.11 [-2.5,28.0] 
TC (mg/dl) 204 (137 - 518) 277 (199 - 479) <200 0.007 [21,90] 
HDL-C (mg/dl) 92 (46 - 141) 104 (52 - 164) >40 0.05 [0,23] 
LDL-C (mg/dl) 116 (64 - 369) 157 (76 - 327) <160 0.01 [11,78] 
TC/HDL-C 2.6 (1.7 – 4.6) 3.1 (1.6 – 6.4) <4.0  0.11 [-0.1,0.7] 
LDL-C/HDL-C 1.5 (0.6-3.3) 2.0 (0.6-4.7) <4.5 0.11 [0.0,0.7] 
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However, in contrast to the observations 
made by Phinney et al. in 9 healthy men after 
a 4-week KD [14], none of our subjects 
exceeded the reference ranges for BUN and 
uric acid. The same was true for creatinine 
except for subject 1 whose creatinine 
concentration increased slightly above the 
reference range from 1.23 mg/dl at PRE to 
1.36 mg/dl at POST. 
 
Energetic substrates and cholesterol levels 
Changes in the levels of blood glucose, 
triacylglycerides (TAG), lipoproteins and the 
thyroid-stimulating hormone (TSH) are 
summarized in Table 5. Blood glucose 
concentrations remained within the reference 
range with a non-significant decrease during 
the study intervention. TAG concentrations 
increased non-significantly and stayed within 
the lower reference range. There was a sig-
nificant increase in LDL-cholesterol (LDL-C) 
and total cholesterol (TC) concentrations, 
accompanied by a trend for an increase in 
HDL-C (Figure 2). We found that TC levels 
were already elevated above the current 
reference range (considered to be at 
200 mg/dl) at PRE in 7 of our 12 subjects. 
After the study, however, TC levels exceeded 
the reference range in all but one of the 
subjects (subject 11 had a POST measure-
ment of 199 mg/dl). In particular, subject 2 
initially showed very high levels of total and 
LDL -C and was immediately informed about 
his blood analysis. He subsequently reduced 
his self-reported intake of eggs and meat and 
increased the amount of plant fats. 
Interestingly, there was a significant 
gender difference in the LDL-C concentration 
at POST and the TC/HDL-C ratio at PRE and 
POST (U-test, all p=0.005) with women 
having lower values than men (Figure 3). 
There are studies suggesting a connection 
between serum lipoprotein concentrations 
and TSH even across the euthyroid range [38, 
39].  
We observed a non-significant increase of 
TSH which is displayed graphically in 
Figure 3. However, subject 11 is not repre-
sentative for the effects of the KD on TSH as 
she took a thyroxin substitute. Omitting her 
from the analysis, the change in TSH 
remained non-significant (p = 0.15). 
 
Performance tests 
The results of our performance tests at 
PRE and POST are shown in Figure 4 with 
dashed and solid lines, respectively, for each 
individual. Black and red lines indicate the 
rise of heart rate and lactate concentrations, 
respectively, over time and with increasing 
running speeds. The vertical lines denote the 
time of exhaustion. 
A comparison of test results between PRE 
and POST is given in Table 6. 
It revealed no significant differences in 
either time to exhaustion, maximum heart 
rate, absolute and relative peak power out-
put, absolute and relative VO2max or heart rate 
at RCP. While maximum lactate concen-
trations showed no significant differences, RQ 
values at exhaustion tended to be lower at 
POST compared to PRE (1.06 (1.0-1.07) vs. 




By studying a series of twelve cases we 
investigated the effects of a self-administered 
KD over at least 5 weeks in healthy and 
physically active adults. This reflects the 
conditions probably encountered in real life 
when an individual decides to implement a 
KD for a restricted period of time. We would 
expect such an individual to be highly 
motivated, physically active and well in-
formed about which foods to eat and which to 
avoid. 
The excellent compliance of our subjects is 
proven by the fact that they quickly reached 
ketosis after 1-5 days and remained therein 
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Figure 2: Changes in total, high density lipoprotein (HDL) and low density lipoprotein (LDL) cholesterol as well 





Figure 3: Changes in TSH levels. Gender is coded according to Figure 2. Note that subject 11 controlled her TSH 
level by taking a thyroxin substitute.
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Figure 4: Lactate (red) and heart rate (red) curves at PRE (dashed lines) and POST (solid lines) for all subjects in ascending order from top left to bottom right. The vertical lines 
denote the time at exhaustion. 
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[ml min-1 kg-1] 
HR at RCP 
[s-1] 
HR at RCP/HRmax 
[%] 
RQmax 
 PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST PRE POST
1 1440 1350 198 195 272 261 3.6 3.6 4643 4132 61.9 57.4 170 172 85.9 88.2 1.06 0.91
2 1530 1380 174 173 285 284 3.6 3.6 5164 5154 65.8 66.1 160 158 92.0 91.3 1.00 0.91
3 1200 1170 167 165 259 245 3.3 3.3 4159 3866 53.7 52.5 150 138 89.8 83.6 1.08 0.92
4 1080 1080 187 182 246 227 3.1 3.0 4267 4196 53.0 55.9 165 168 88.2 92.3 1.13 0.97
5 810 780 189 187 238 240 2.7 2.8 4583 4704 52.4 54.2 171 165 90.5 88.2 0.91 1.02
6 900 900 181 179 190 183 2.7 2.7 3629 3264 51.7 48.1 154 148 85.1 82.7 1.00 0.99
7 450 510 183 183 203 199 2.2 2.2 3608 3351 38.6 36.4 160 158 87.4 86.3 1.07 1.03
8 990 1020 203 201 182 176 3.0 3.0 3436 3420 56.3 58.0 180 181 88.7 90.0 1.06 1.05
9 900 900 174 177 186 189 2.7 2.7 3205 3260 47.3 46.5 158 163 90.8 92.1 1.06 1.02
10 630 720 195 206 164 159 2.4 2.4 2618 2859 38.3 43.1 175 180 89.7 87.4 1.04 0.99
11 630 630 195 193 173 170 2.4 2.4 3375 3201 46.6 45.2 170 175 87.2 90.7 0.91 0.93
12 360 420 184 175 81 98 1.7 2.0 1640 1737 33.8 35.6 171 162 92.9 92.6 1.07 0.97
Median 900 900 186 183 197 194 2.7 2.8 3619 3386 52.1 50.3 168 164 89.2 89.1 1.06 0.98
95% CI [-60,90] [-4,3] [-10,1] [-0.1,0.3] [-261,55] [-1.8,1.8] [-5,3] [-2.3,1.7] [-0.1,-0.01] 
p-value 0.95 0.21 0.08 0.79 0.20 0.97 0.50 0.91 0.03 
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for most of the time as judged by the 59-
100 % of positive urinary tests.  
They also reported that these measure-
ments had been taken temporally offset from 
any exercise, so that we can exclude ketone 
production being due solely to exercise. We 
point out, however, that urinary ketone 
measurements neither reflect actual endo-
genous ketone production nor our subject’s 
adherence to the target CHO restriction as 
ingested protein above ones needs can 
attenuate ketone production through an 
increased gluconeogenesis and can increase 
ketone excretion by elevation of insulin 
levels. Analysis of available food diaries 
indicates that adherence to our prescribed 
CHO intake was excellent (<20 g/day), but 
protein intake might indeed have been high 
(29±5 % of energy intake). We hypothesize 
that this may reflect more protein-rich food 
choices of physically active individuals on 
self-prescribed KDs. 
The KD was well tolerated by the majority 
of our subjects as judged by personal contact, 
email exchanges and the questionnaires they 
returned after the study. Apart from exercise, 
most subjects were in a good mood and even 
reported improvements of several subjective 
feeling like less tiredness and improved 
ability for mental concentration. Although all 
subjects noted a subjective improvement in 
their exercise capacity after 2-3 weeks 
impaired recovery thereafter, and increased 
perceived exertion during more intensive 
workouts remained the strongest side effects 
until the end of the study. This can be seen as 
problematic for individuals undergoing high-
intensity exercise in the context of com-
petitive training as in the case of subjects 1, 2, 
7 and 12. These side-effects could reflect 
shortcomings in the self-prescribed diet plans 
to meet the required micronutrient intakes 
[40, 41] or to compensate for urinary mineral 
losses [42] or transient energy deficits due to 
protein-induced satiety [43] (one third of our 
subjects reported less hunger during the 
intervention). Most importantly, however, we 
think that the KDs resulted in a chronic 
depletion of muscular glycogen stores [13] 
that could have caused symptoms of exercise-
related fatigue and delayed recovery [44–46]. 
Low glycogen availability during exercise 
exacerbates the release of the myokine 
interleukin-6 that either directly or indirectly 
through interaction with immune cells may 
act on the central nervous system to induce 
fatigue [47]. Although ample protein in-
gestion after exercise could be sufficient to 
maximally stimulate muscle protein synthesis 
[48, 49], additional CHO intake seems neces-
sary to maximize the speed of recovery and 
attenuate exercise-induced immune suppres-
sion [44], at least in subjects not fully adapted 
to ketosis. 
 
Influence on body composition 
Consistent with previous studies, there 
was a mild weight loss of 1.7 kg. A remarkable 
finding was the increase of the phase angle α 
in ten of our twelve subjects, which was due 
to a decrease of resistance R (reflecting fluid 
losses) and increase of reactance Xc 
(reflecting higher capacitive resistance indi-
cative of a better integrity of cell walls). The 
median increase of 0.3 ° was larger than the 
individual measurement uncertainties of 
0.1 °. α has also been interpreted as a “muscle 
index” [50], and larger values are related to 
better outcomes in many clinical situations, 
e.g. in cancer and malnourished patients [50–
53]. Single-frequency BIA at 50 kHz seems to 
primarily measure extracellular water (ECW) 
[54], while changes in intracellular water 
(ICW), which contributes to body cell mass, 
cannot be accurately measured [33]. Body 
composition estimates rely on a stable 
relationship between ECW, ICW and fat free 
mass (FFM) that could have been altered 
during the KD. In addition, we have to take 
into account intra-individual prediction 
errors that Kyle et al. summarized as 3-8 % 
for total body water and 3.5-6 % for FFM 
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[33]. Our Monte Carlo simulations showed 
that, assuming a prediction error of 3.5 %, in 
only 2.2 % of all simulated datasets FM 
increased (i.e. its median change was greater 
than 0) while in 12 % FFM decreased. The 
simulated p-values for changes in FM 
remained less than 0.05 for assumed FFM 
prediction errors up to 4 %. 
While this confirms the non-significant 
gains in FFM, the observed loss of FM seems 
fairly robust even taking into account typical 
measurement uncertainties. This is further 
supported by the indication of ECW losses at 
POST through the slightly higher haematocrit 
values. Because FM is estimated from the 
difference between total body weight and 
FFM, a rapid loss of water (which contributes 
to FFM) would even result in an over-
estimation of FM at POST. However, similar to 
fasting, this effect would be most severe 
during the first week of the diet, while after at 
least five weeks we could expect a more 
stable situation [55]. In fact, none of our BIA 
measurements indicated an abnormal 
hydration status at either PRE or POST 
according to the RXc graph of Piccoli et al. 
[56] (not shown here). This graphical 
interpretation has the advantage of assessing 
an individual’s nutritional health status based 
on the directly measured impedance vector 
without relying on predictive equations or 
models. It confirms that the KD favourably 
affected body composition as indicated by 
higher phase angles at POST, even if the exact 
amounts of FFM gained and FM lost are 
somewhat uncertain due to the limitations of 
BIA. We point out that these findings have 
important implications for the nutrition of 
critically ill patients, who often suffer from 
muscle wasting and whose survival time 
strongly and positively correlates with phase 
angle [51–53]. 
We can rule out strength training as the 
general cause of the observed increase in α, 
because only subjects 1, 2, 7, 11 and 12 
conducted strength training during the study 
period and α actually decreased slightly in 
subjects 7 and 12 (the two weight lifters). An 
alternative explanation could be - at least in 
part - the muscle-sparing effect of ketosis that 
is essential for surviving longer periods of 
starvation [57]. Rat studies provided evi-
dence that physiological levels of ketone 
bodies inhibit oxidation of the branched chain 
amino acids in muscle [58] and decrease the 
release of the gluconeogenic amino acid 
alanine [59]. Interestingly, the cyclists studied 
by Phinney et al. had significant elevations of 
fasting plasma leucine, isoleucine and valine 
levels that were most pronounced during the 
first week of their KD [14]. Furthermore, it 
has been shown that the hyperaminoacidemia 
resulting from ample protein ingestion after 
exercise is sufficient to maximally stimulate 
muscle protein synthesis and maximally 
impair protein breakdown by increasing 
insulin to sufficient levels of ≥30 mU/l 
without the need for additional CHO [48, 49]. 
 
Lipid profile and cardiovascular disease 
risk 
Consistent with the findings of Phinney et 
al. (14), most blood parameters in our 
subjects remained fairly stable and within the 
reference ranges, although large individual 
differences existed (Table 2). An exception 
was the significant elevation in total 
cholesterol (TC) and LDL-C concentrations in 
all of our subjects (Fig.2). This is consistent 
with the significant elevations of TC and LDL-
C levels reported by previous studies of 
normolipidemic and normal-weight healthy 
[23, 26–28] as well as epileptic [35] adults 
after a few weeks to a few months on a KD. In 
obese adults on a one-year KD, a significant 
increase of LDL-C was observed as well [12]. 
Studies in athletes reported either increased 
[14, 60] or unchanged [17, 61–63] TC and 
LDL-C concentrations after high-fat, partly 
ketogenic diets of various duration. Apparent-
ly, elevated LDL-C levels are a consequence of 
increased saturated fat intake [64, 65] and 
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can be measured as early as after three days 
[66], but we refrained from correlating 
saturated fat intake with individual LDL 
changes because of the small number of 
available food diaries. Our study subjects at 
POST compared well to the “optimal” dieters 
from Poland who showed median LDL-C and 
TC concentrations of 177.1 and 268.7 mg/dl, 
respectively, after at least one year on this 
very low CHO diet [30]. Hypercholesterolemia 
was also observed in Vilhjalmur Stefansson 
and Karsten Andersen during their one year 
exclusive meat diet, but TC levels returned to 
normal after discontinuation of the diet [23]. 
Notably, the maximum TC level of Andersen 
had been measured as 800 mg/l. Thus it could 
be questioned whether KDs increase 
cardiovascular disease (CVD) risk. 
Elevated LDL-C is seen as a risk factor for 
atherosclerosis and CVD, for which reason 
fat-enriched diets are regarded as critical. 
There is evidence, however, that CHO-
restricted and fat-enriched diets do not 
necessarily raise the number of total LDL 
particles, but rather induce a change in the 
size of these particles [28, 66–68] so that the 
number of small dense LDL particles 
decreases while that of large LDL particles 
increases. It has been argued that large LDL 
particles have a lower atherogenic potential 
as they are less able to migrate from the 
lumen into the subendothelial space of blood 
vessels and seem to be less susceptible to 
oxidation [69]. Although a larger number of 
small and intermediate LDL particles has 
often been correlated with an increased risk 
for CVD in univariate analyses, the predictive 
role of LDL particle size is questioned through 
multivariate analyses that established plasma 
triacylglycerides (TAG) and the TC/HDL-C 
ratio as more reliable independent predictors 
of CVD (see [70] and references therein). 
Our measurements indicate a blood lipid 
profile (elevated TC, HDL-C and LDL-C, 
unchanged low TAG) that would be consistent 
with the mechanisms mentioned above. Large 
LDL-particles carry more total cholesterol 
while the TAG content seems to decrease or 
only change slightly. This gives rise to 
increased LDL-C with stable or decreased 
TAG as shown by Guay et al. in normo-
lipidemic men [66]. Because we have no 
assessment of lipoprotein subclasses in our 
subjects, we can only speculate about an 
atherogenic potential of the KD based on the 
risk estimates that adopt CRP, TC, LDL-C and 
HDL-C [62]. In 11 and 9 of our 12 subjects, 
respectively, the LDL-C/HDL-C and TC/HDL-C 
ratios remained within the reference range 
(Table 2), whereby subject 2 already had a 
TC/HDL-C ratio of 4.6 at PRE and reached 4.1 
at POST. Combined with the low TAG and CRP 
levels, this indicates that the KD does not 
necessarily increase the risk for CVD. 
It is interesting to note that TAG levels did 
not decrease, but slightly increased in our 
participants. This is unexpected in light of 
previous studies usually showing a reduction 
in TAG when CHOs are restricted [12]. 
However, this effect is also most prominent in 
insulin-resistant individuals with elevated 
TAG levels. Our healthy subjects had already 
low TAG values initially and as athletes are 
expected to be insulin sensitive. This could 
explain the lack of reduction of TAG levels. 
In subjects 1 and particularly 2, very high 
TC and LDL-C concentrations were measured 
PRE and POST. In these cases, a genetic 
predisposition must be considered. At least 
for subject 2 we cannot rule out a familial 
hypercholesterolemia since a maternal dys-
lipidemia was known. 
Another mechanism for the rise in 
cholesterol levels in our subjects could be 
related, at least in part, to a potential drop in 
the circulating thyroid hormones thyroxine 
(T4) and triiodothyronine (T3), as indicated by 
the rise in TSH levels. T3 (and to a lesser 
extent T4) stimulates the expression of the 
LDL receptor on hepatic and peripheral cells 
through binding to its nuclear receptor and 
subsequent activation of thyroid response 
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elements on the promoter region of the LDL 
receptor gene [71–73]. Less T3 would 
therefore result in less LDL receptors and 
decreased clearance of LDL particles from the 
circulation. Both in vitro [74] and in vivo [14, 
75–79] studies have indeed shown that 
severe CHO restriction reduces T3 levels 
within several days similar to fasting by 
impairing the conversion of T4 to T3. Although 
in these experiments, which lasted a 
maximum of two weeks, TSH was either not 
measured, remained stable or decreased, our 
observations indicate that in the longer term 
TSH levels might increase in response to 
lower circulating thyroid hormones. 
Interestingly, subject 11 who took a thyroxin 
substitute experienced the least dramatic rise 
in LDL levels. Furthermore, positive 
associations between TSH and LDL as well as 
total cholesterol levels have been found in 
cross-sectional studies in euthyroid healthy 
subjects, and the strength of these asso-
ciations seems to depend on an individual’s 
insulin sensitivity [38, 39]. We therefore 
hypothesize that the KD has diminished the 
production of T3 from T4, thereby reducing 
the number of LDL receptors and thus 
reducing LDL particle clearance which might 
be further impaired due to the missing 
stimulating effect of insulin on LDL uptake 
into cells [71]. 
 
Impact on kidney function 
Previous studies have also shown that KDs 
lasting for at least a few weeks can result in 
significant elevations of uric acid [14, 26], 
blood urea nitrogen (BUN) [26, 28] and 
creatinine [14]. Increases in uric acid have 
been attributed to the effect of ketone bodies 
competing with tubular uric acid transport in 
the kidneys [80, 81]. This would result in a 
retention of uric acid when ketone bodies are 
excreted, leading to a positive association 
between serum uric acid levels and urinary 
ketone concentrations as already observed by 
Krehl et al. [26]. Elevations of BUN have been 
interpreted as a physiological consequence of 
increased protein intake [26, 28]. It should 
further be noted that especially during the 
initial phase of ketosis, protein breakdown 
and amino acid catabolism are increased to 
enable ATP and glucose production which 
also leads to increases in BUN. Finally, 
elevated ketone bodies could give rise to 
higher serum creatinine concentrations by 
interfering with the Jaffé reaction [82]. Con-
sistent with these mechanisms, we observed 
elevations of uric acid, BUN and creatinine in 
our subjects, the latter with a clear trend 
(p=0.016). Estimated glomerular filtration 
rate according to the MDRD equation [83] 
revealed a decrease from a median of 
91.8 ml/min/1.73 m2 to 82.9 ml/min/1.73 m2 
(p=0.021). However, given that elevated 
creatinine concentrations could simply reflect 
relative muscle mass and considering the 
uncertainties in that equation for healthy 
individuals, a negative impact of the KDs on 
kidney function seems unlikely but cannot be 
ruled out with certainty. Unfortunately, from 
our data, we are neither able to track the 
exact changes in kidney blood parameters 
over time nor to relate them to precise 
measurements of macronutrient intake. 
 
Influence on running performance 
According to our test results, several 
weeks of a KD did not impair running 
performance in our study cohort, although 
great inter-individual differences existed. In 
particular, there were no significant diffe-
rences in VO2max as well as the HR at RCP. The 
RCP can be interpreted as a threshold 
towards the high intensity zone. As anaerobic 
energy production begins to increase dis-
proportionate to intensity, H+-ions start to 
accumulate in the extra-cellular space (meta-
bolic acidosis), leading to a respiratory 
compensation through increased ventilation. 
This point is therefore defined as the 
respiratory compensation point. In our study 
design, the RCP might be a better indicator of 
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running intensity than the anaerobic 
threshold usually derived from the lactate-
curve, because it is known that lactate 
kinetics are influenced by the amount of 
stored glycogen while the minimum in the 
VE/VCO2 curve is not (Fig.7 in Hughes et al. 
[84]). 
In this regard, we do not judge lactate- or 
RQ-kinetics as relevant performance indica-
tors, because they are influenced by diet 
composition. It is interesting to note, how-
ever, that similarly high lactate concentra-
tions were reached at POST compared to PRE 
despite the ketogenic nature of the diets. This 
indicates that glycogen stores were not fully 
depleted during the exercise protocol. Never-
theless, maximum RQ values tended to be 
lower at POST compared to PRE reflecting a 
shift in fuel utilization towards fat oxidation 
in line with the findings of previous studies 
on obese [13, 18] or lean [15] subjects after at 
least three weeks on a KD. In these studies, no 
detrimental effects of the KD on VO2max values 
have been found, contrary to shorter-term 
studies allowing a maximum of two weeks for 
adaption. Phinney [42] summarized these 
findings to conclude that three main factors 
may explain the conflicting results: extra 
sodium and potassium intake (that was not 
controlled for in this study); ample protein 
ingestion (that probably was given in our 
subjects based on the available food diaries); 
and most importantly sufficient time for 
metabolic adaption to chronically low CHO 
intake, probably two weeks and more. This 
coincides with the subjective feeling of 
improved exercise performance and recovery 
after 2-3 weeks reported by our subjects, and 
would explain the restoration of exercise 
capacity at POST. 
Relative VO2max values are frequently used 
in the literature to compare exercise capacity 
after an intervention [18, 19]. However, these 
values should be interpreted with caution 
since our subjects were lighter at POST than 
at PRE. The same caveat applies to the 
relative peak power values. Nevertheless, 
changes in the absolute measures of these 
variables did not reach statistical significance. 
In conclusion, our treadmill test results 
imply that drastically reducing the amount of 
CHOs in the diet was no limiting factor for 
running performance in our 12 subjects. 
Intensity was maintained with increased fat 
oxidation rates. In principle, spiroergometric 
parameters can be used for interpreting 
(VO2max) as well as controlling (RCP) the 
training load. 
 
Limitations of the study 
Our study has several limitations. The 
most obvious is the heterogeneity of our 
sample with respect to age, gender, main 
sport as well as amount and intensity of 
training. However, we see this more as an 
advantage to the statistical modelling since 
our goal was to infer general changes that 
would occur in healthy individuals 
independent from the factors listed above. 
Nevertheless, our conclusions should be 
interpreted as hypotheses that warrant 
further testing with larger sample sizes. As a 
small interventional case study, there was no 
control group against which we could have 
compared any changes. 
Another point for critique could be the 
lack of control regarding energy intake as 
well as quality and quantity of macro-
nutrients. For example, fat quality has a large 
impact on cholesterol levels and we are not 
able to disentangle these effects from others 
like CHO restriction or energy intake. 
However, our goal was to study the effects of 
a KD as it would be practiced in a free-living 
population, where inter-individual variations 
in diet compositions naturally occur; again, 
this can be seen as an advantage for 
identifying common effects that are due to 
some general mechanisms of a KD. In this 
context, the somewhat high protein 
consumption derived from analyzing a 
sample of three-day food diaries from five 
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subjects might simply reflect the real life 
situation. It did not, however, diminish 
nutritional ketosis as judged by the daily 
urinary ketone measurements. 
Regarding the performance tests, several 
confounding factors exist. First, women were 
not in the same menstrual cycle phase for all 
measurements. Second, only a few subjects 
monitored their training, and we cannot rule 
out the possibility that the others increased 
their training volume and/or intensity during 
the intervention, although subjects affirmed 
this not to be the case. Third, diet 
composition on the days before the two tests 
was not standardized. Also, we cannot infer 
how the second test would have been if 
subjects would have been allowed to eat a 
high-CHO diet on the day before. Fourth, the 
lack of monitoring training opens the 
possibility that changes in running 
performance simply reflect the influence of 
altered physical training. Nevertheless, our 
results indicate that for most subjects, 
exercise capacity was not compromised by 
the very low CHO content of their diet, given 
several weeks of adaptation. 
Finally, we did not measure hormonal 
changes except TSH that might underlie some 




Several weeks of a self-prescribed KD did not 
cause major health problems, and even 
improved some subjective parameters like 
mood state, in twelve active individuals from 
a variety of sports, although subjective 
recovery from exercise was impaired. 
The drastically reduced carbohydrate con-
tent of the diet seems to be no limiting factor 
for running performance. In addition, there 
was an improvement in body composition 
indicated through significantly higher phase 
angles, and loss of FM. While most 
biochemical parameters were not influenced 
by the diet, there was an impact on the blood 
lipid profile that can be considered problema-
tic with respect to cardiovascular disease risk. 
As we discussed, however, the predictive role 
of cholesterol levels alone in healthy, 





Additional file 1 is an English version of the 
questionnaire sent to our study subjects after 
the intervention period. Where there was a 
choice from a list of possible answers, each 
“x” indicates that one subject chose the 
corresponding answer. We have also included 
individual remarks in the file with the 
corresponding subject number given in front 
of each remark. 
 
 
LIST OF ABBREVIATIONS 
BCM = Body cell mass; BUN = Blood urea 
nitrogen; BW = Body weight; CI = Confidence 
interval; CHO = Carbohydrate; ECM = 
Extracellular mass; ECW = Extracellular 
water; FFM = Fat free mass; FM = Fat mass; 
HDL-C = HDL cholesterol; ICW = Intracellular 
water; KD = Ketogenic diet; LDL-C = LDL 
cholesterol; RCP = Respiratory compensation 
point; TAG = Triacylglyceride; TBW = Total 
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